Humacyte, Inc. (HUMA) Balance Sheet
As of 2026-06-30 (10-Q), Humacyte, Inc. (HUMA) reported total assets of $138.1M, total liabilities of $106.8M and shareholders' equity of $31.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $79.9M. Long-term debt: $36.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HUMAHumacyte, Inc.Follow HUMA — free
—
Price chart with a free account
- Market cap
- 121.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 39.9 | 217.5 | 149.8 | 80.4 | 44.9 | 50.5 | 79.9 | |
| Short-term investments | 0.0 | 8.0 | 2.1 | 0.0 | — | — | — | |
| Receivables | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.3 | |
| Inventory | — | — | — | — | 0.0 | 13.6 | 7.0 | |
| Current assets | 41.4 | 229.3 | 154.2 | 83.3 | 47.9 | 67.8 | 92.8 | |
| Total assets | 106.7 | 286.5 | 204.3 | 128.2 | 137.9 | 116.4 | 138.1 | |
| Current liabilities | 11.2 | 11.1 | 19.6 | 18.4 | 20.0 | 18.4 | 14.9 | |
| Long-term debt | — | 30.0 | — | — | 0.0 | 35.4 | 36.3 | |
| Total liabilities | 36.0 | 164.4 | 87.4 | 114.7 | 190.5 | 113.3 | 106.8 | |
| Shareholders' equity | -350.3 | 122.2 | 116.9 | 13.5 | -52.7 | 3.1 | 31.3 |
USD millions · SEC XBRL
Humacyte, Inc. — questions
- How much cash does Humacyte, Inc. have?
- $79.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does Humacyte, Inc. have?
- $36.3M of long-term debt as of 2026-06-30.
- What are Humacyte, Inc.'s total assets?
- $138.1M as of 2026-06-30.
- What is Humacyte, Inc.'s shareholders' equity?
- $31.3M as of 2026-06-30.
Every figure on this page comes from Humacyte, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.